660120login-checkReview Probes Intricacies of Protecting Kidney Transplant Recipients From COVID-19 |
By Jared Kaltwasser
Vaccines were safe in transplant recipients, but their efficacy was affected by immunosuppressive therapies.
People who undergo kidney transplantation appear to have better outcomes from COVID-19 compared with those waiting for transplants, according to a new review.
However, the report also found that the immunosuppressive regimens associated with the procedure can complicate efforts to protect patients from the virus. The report was published in Cureus. Read more from the American Journal of Managed Care (AJMC).
660120login-checkReview Probes Intricacies of Protecting Kidney Transplant Recipients From COVID-19 |